GGFO10120
| Product Description: |
Nicotinic acid was isolated as a pure chemical substance in 1867, but not until 1937 was it dsicovered to be the anti-PELLAGRA vitamin for humans. Classical deficiency of niacin, Pellagra, is characterised by the four D's - dermatitis, dementia, diarhoea, and death. Nicotinic acid is produced from tryptophan in the body and is then converted into niacinamide. Nicotinic acid functions in the body as a component in the coenzymes nicotinamide adenine dinucleotide (NAD) and NADP, which are involved in approximately 200 enzyme processes.
BLOOD SUGAR LOWERING - Niacinamide shows effectiveness in diabetic conditions by prolonging non-insulin requiring remission, lowering insulin requirements, improving metabolic control, and increasing pancreatic beta-cell function. Nicotinic acid along with chromium is thought to be a component of glucose tolerance factor (GTF) that potentiates the action of insulin.
ARTHRITIS - niacinamide has shown good clinical results in the treatment of hundreds of patients with rheumatoid and osteoarthritis. Results demonstrate improved joint flexibility, and reduced inflammation in those receiving supplementation over 12 weeks.
|
| HealthWarning: |
It should also not be used by those with liver disease or peptic ulcers.
|
| Nutrition Information: |
|
Elevated blood lipids i.e. elevated cholesterol levels, hyperglycaemia, diabetes, intermittent claudication, Raynaud's phenomena, rheumatoid and osteoarthritis. Niacinamide has been shown to be a tumour-specific radio-sensitizer, possibly because of its effect on vaso-relaxation and increased tumour oxygenation.
|
|
